Michael Platten Selected Research

Ischemic Stroke

1/2022	Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
1/2021	[Acute ischemic stroke and elevated troponin: Diagnostic work-up and therapeutic consequences].
1/2020	Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Platten Research Topics

Disease

114	Neoplasms (Cancer) 05/2024 - 12/2003
83	Glioma (Gliomas) 01/2024 - 09/2003
62	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 12/2003
31	Multiple Sclerosis 12/2023 - 10/2003
15	Brain Neoplasms (Brain Tumor) 12/2023 - 02/2015
11	Inflammation (Inflammations) 01/2023 - 10/2007
11	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 07/2012
6	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 11/2005
6	Neuroinflammatory Diseases 10/2019 - 11/2005
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 11/2005
5	Disease Progression 10/2022 - 01/2016
4	Atrophy 11/2023 - 03/2019
4	Melanoma (Melanoma, Malignant) 11/2023 - 02/2015
4	Stroke (Strokes) 01/2022 - 01/2018
4	Infections 10/2020 - 07/2012
3	Ischemic Stroke 01/2022 - 01/2020
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 10/2003
3	Starvation 08/2016 - 10/2007
2	Multiple Myeloma 10/2023 - 10/2022
2	Thrombocytopenia (Thrombopenia) 01/2023 - 07/2012
2	Oligodendroglioma 05/2022 - 01/2015
2	Meningioma (Meningiomas) 12/2021 - 01/2018
2	Hypoxia (Hypoxemia) 01/2021 - 01/2014
2	Experimental Melanoma 01/2021 - 01/2016
2	Hypersensitivity (Allergy) 01/2020 - 01/2014
2	Edema (Dropsy) 04/2019 - 04/2011
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

29	Tryptophan (L-Tryptophan)FDA Link 11/2023 - 11/2005
28	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2011
25	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 09/2010
18	AntigensIBA 01/2024 - 02/2015
18	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 08/2007
16	EnzymesIBA 01/2021 - 10/2007
15	VaccinesIBA 01/2024 - 08/2014
13	Bevacizumab (Avastin)FDA Link 10/2023 - 03/2011
12	KynurenineIBA 01/2021 - 10/2007
11	IronIBA 11/2023 - 01/2017
11	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2003
9	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2019
8	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2017
8	Peptides (Polypeptides)IBA 01/2024 - 01/2016
8	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2023 - 10/2011
8	Essential Amino AcidsIBA 01/2021 - 09/2012
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2005
7	MethyltransferasesIBA 01/2019 - 08/2007
6	Protein Subunit VaccinesIBA 02/2024 - 01/2021
6	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 11/2018
6	EpitopesIBA 11/2023 - 02/2015
6	Alkylating AgentsIBA 10/2014 - 02/2009
5	Lomustine (CCNU)FDA Link 10/2023 - 01/2015
5	LigandsIBA 12/2022 - 12/2003
5	Phosphotransferases (Kinase)IBA 01/2018 - 11/2004
5	Messenger RNA (mRNA)IBA 01/2018 - 09/2010
4	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 11/2004
4	O(6)-Methylguanine-DNA MethyltransferaseIBA 07/2014 - 08/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 01/2019
3	OvalbuminIBA 11/2023 - 01/2021
3	Methionine (L-Methionine)FDA Link 10/2023 - 01/2017
3	Lysine (L-Lysine)FDA Link 10/2023 - 01/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023 - 01/2020
3	Histones (Histone)IBA 10/2023 - 01/2012
3	Chimeric Antigen ReceptorsIBA 01/2023 - 07/2022
3	ProteomeIBA 12/2022 - 11/2018
3	GadoliniumIBA 12/2021 - 01/2019
3	Contrast MediaIBA 12/2021 - 03/2018
3	SodiumIBA 04/2021 - 04/2019
3	Cancer VaccinesIBA 01/2021 - 02/2015
3	Amino Acids FDA Link 01/2021 - 01/2017
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020 - 12/2013
3	AntibodiesIBA 12/2016 - 08/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 03/2011
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2015 - 10/2007
2	NucleotidesIBA 01/2024 - 01/2016
2	HLA-A Antigens (HLA-A)IBA 01/2024 - 01/2019
2	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 01/2014
2	B7-H1 AntigenIBA 05/2022 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 03/2018
2	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2017
2	Codon (Codons)IBA 01/2021 - 01/2017
2	DioxygenasesIBA 01/2020 - 09/2012
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2015
2	alpha-hydroxyglutarateIBA 11/2019 - 01/2017
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 12/2013
2	Fas Ligand Protein (Fas Ligand)IBA 01/2018 - 12/2014
2	APG101IBA 01/2018 - 12/2014
2	temsirolimus FDA Link 10/2016 - 03/2016
2	enzastaurinIBA 03/2016 - 10/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2016 - 10/2015
2	Retinaldehyde (Retinal)IBA 03/2016 - 01/2016
2	AutoantigensIBA 01/2016 - 11/2005
2	GlucocorticoidsIBA 01/2015 - 01/2014

Therapy/Procedure

54	Therapeutics 05/2024 - 12/2003
38	Immunotherapy 11/2023 - 12/2003
19	Radiotherapy 12/2023 - 12/2008
18	Drug Therapy (Chemotherapy) 01/2023 - 08/2007
6	Chemoradiotherapy 11/2021 - 06/2013
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024 - 11/2021
2	Salvage Therapy 01/2019 - 03/2014